2 years ago
BKNG
AnalystsEdward WooEdward Woo's Stock Forecasts
AnalystsEdward Woo
Analyst Ranking
Top 7%
#311 out of 5020 analysts
Average Return
+14.3%
Win Rate
45%83 out of 185
Risk vs Reward
Poor
Good
Edward Woo's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Aim Immunotech IncAIM | +1,069.72% | $0.22 | $2.55 | 2024-12-09 - 2025-09-17 | Buy |
Streamex CorpSTEX | +1,062.92% | $0.53 | $6.21 | 2025-04-20 - 2025-09-17 | Buy |
Aim Immunotech IncAIM | +595.40% | $0.35 | $2.42 | 2024-09-02 - 2025-09-02 | Buy |
Quantum Computing IncQUBT | +593.18% | $0.88 | $6.10 | 2023-11-23 - 2024-11-22 | Buy |
Quantum Computing IncQUBT | +565.79% | $2.66 | $17.71 | 2024-11-12 - 2025-09-17 | Buy |
Edward Woo Analyst Color
Get additional color on Edward Woo's coverage of popular stocks
Edward Woo's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Maison Solutions IncMSS | 1 | Buy | $4.00 | +320.17% | Initiates Coverage On | 3 days ago |
TravelzooTZOO | 5 | Buy | $26.00 | +166.39% | Maintains | 23 days ago |
Igc Pharma IncIGC | 6 | Buy | $4.50 | +1,000.24% | Maintains | 23 days ago |
Renovorx IncRNXT | 6 | Buy | $12.00 | +883.61% | Maintains | 24 days ago |
Cingulate IncCING | 3 | Buy | $62.00 | +1,575.68% | Maintains | a month ago |
Alzamend Neuro IncALZN | 5 | Buy | $45.00 | +1,700.00% | Maintains | a month ago |
Allarity Therapeutics IncALLR | 1 | Buy | $9.00 | +512.24% | Initiates Coverage On | 2 months ago |
Aytu Biopharma IncAYTU | 1 | Buy | $12.00 | +417.24% | Initiates Coverage On | 3 months ago |
Duos Technologies Group IncDUOT | 6 | Buy | $11.00 | +48.25% | Maintains | 3 months ago |
Surgepays IncSURG | 7 | Buy | $9.00 | +205.08% | Maintains | 3 months ago |
Outlook Therapeutics IncOTLK | 4 | Buy | $21.00 | +1,958.82% | Maintains | 3 months ago |
Phunware IncPHUN | 6 | Buy | $12.50 | +354.55% | Maintains | 3 months ago |
Streamex CorpSTEX | 4 | Buy | $10.00 | +61.03% | Maintains | 3 months ago |
Aemetis IncAMTX | 3 | Buy | $20.00 | +817.43% | Maintains | 3 months ago |
Atossa Therapeutics IncATOS | 5 | Buy | $7.50 | +803.61% | Maintains | 3 months ago |
Lucid Diagnostics IncLUCD | 6 | Buy | $7.75 | +624.30% | Maintains | 3 months ago |
Pavmed IncPAVM | 6 | Buy | $19.00 | +4,602.97% | Maintains | 3 months ago |
Quantum Computing IncQUBT | 4 | Buy | $22.00 | +24.22% | Maintains | 3 months ago |
Knightscope IncKSCP | 3 | Buy | $26.00 | +332.61% | Maintains | 3 months ago |
Genasys IncGNSS | 3 | Buy | $5.50 | +119.12% | Maintains | 3 months ago |
Plus Therapeutics IncPSTV | 4 | Buy | $20.50 | +4,780.95% | Maintains | 3 months ago |
Myomo IncMYO | 4 | Buy | $11.50 | +1,278.90% | Maintains | 3 months ago |
Ton Strategy CoTONX | 4 | Buy | $62.00 | +774.47% | Maintains | 4 months ago |
Endra Life Sciences IncNDRA | 3 | Buy | $46.00 | +876.65% | Maintains | 4 months ago |
Intrusion IncINTZ | 4 | Buy | $11.00 | +543.27% | Maintains | 4 months ago |
Sintx Technologies IncSINT | 2 | Buy | $28.00 | +612.47% | Maintains | 4 months ago |
Banzai International IncBNZI | 5 | Buy | $240.00 | +11,167.61% | Maintains | 4 months ago |
Gri Bio IncGRI | 3 | Buy | $34.00 | +1,670.83% | Maintains | 4 months ago |
Envoy Medical IncCOCH | 5 | Buy | $9.50 | +619.70% | Maintains | 4 months ago |
Society Pass IncorporatedSOPA | 5 | Buy | $15.00 | +1,160.50% | Maintains | 4 months ago |
Pro Dex IncPDEX | 4 | Buy | $56.00 | +71.31% | Maintains | 4 months ago |
Nrx Pharmaceuticals IncNRXP | 5 | Buy | $46.00 | +1,475.34% | Maintains | 5 months ago |
Groupon IncGRPN | 8 | Buy | $19.00 | -13.28% | Maintains | 6 months ago |
Daxor CorpDXR | 3 | Buy | $25.00 | +118.91% | Maintains | 6 months ago |
Electronic Arts IncEA | 2 | Buy | $160.00 | -7.83% | Maintains | 7 months ago |
Take Two Interactive Software IncTTWO | 11 | Buy | $270.00 | +7.78% | Maintains | 7 months ago |
Aim Immunotech IncAIM | 2 | Buy | $4.50 | +76.47% | Maintains | 9 months ago |
Datavault Ai IncDVLT | 3 | Buy | $11.00 | +3,107.00% | Maintains | 9 months ago |
Biolase IncBIOL | 2 | Buy | $2.00 | N/A | Maintains | a year ago |
Mira Pharmaceuticals IncMIRA | 1 | Buy | $11.00 | N/A | Initiates Coverage On | a year ago |
Jakks Pacific IncJAKK | 1 | Buy | $38.00 | N/A | Maintains | a year ago |
Booking Holdings IncBKNG | 2 | Buy | $3,900.00 | N/A | Maintains | 2 years ago |
Expedia Group IncEXPE | 1 | Buy | $168.00 | N/A | Maintains | 2 years ago |
Tripadvisor IncTRIP | 1 | Buy | $30.00 | N/A | Maintains | 2 years ago |
Algorhythm Holdings IncRIME | 1 | Buy | $4.00 | N/A | Initiates Coverage On | 2 years ago |
Heartsciences IncHSCS | 1 | Buy | $330.00 | N/A | Initiates Coverage On | 3 years ago |
Vivos Therapeutics IncVVOS | 1 | Buy | $62.50 | N/A | Initiates Coverage On | 3 years ago |
Autoweb IncAUTO | 1 | Hold | $0.39 | N/A | Downgrades | 3 years ago |
Guardion Health Sciences IncGHSI | 1 | Buy | $37.50 | N/A | Initiates Coverage On | 3 years ago |
Blackboxstocks IncBLBX | 1 | Buy | $24.00 | N/A | Initiates Coverage On | 3 years ago |
Novabay Pharmaceuticals IncNBY | 3 | Buy | $4,900.00 | N/A | Maintains | 3 years ago |
Activision Blizzard IncATVI | 3 | Buy | $95.00 | N/A | Maintains | 3 years ago |
Gamestop CorpGME | 8 | Sell | $5.75 | N/A | Maintains | 4 years ago |
Blue Nile IncNILE1 | 1 | Buy | $6.00 | N/A | Initiates Coverage On | 4 years ago |
Imac Holdings IncBACK | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.